Highlights and Quick Summary
- Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending December 31, 2022 was -23.61% (a 208.63% increase compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -605.57%
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2022 was -7.67% (a -73.07% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was -28.48% (a 8.29% increase from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was -26.3% (a 24.12% increase from previous year)
- Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending December 31, 2022 was -7.67% (a -27.85% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -68.54% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -7.67% | -10.63% | -24.5% | -24.38% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative (SG&A) Expenses Growth of Precigen, Inc.
Most recent Selling, General and Administrative (SG&A) Expenses Growthof PGEN including historical data for past 10 years.Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Precigen, Inc.
Precigen, Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -23.61% | -7.65% | -15.27% | 4.67% | -7.67% |
| 2021 | -33.26% | -50.8% | -16.31% | -12.96% | -28.48% |
| 2020 | -57.82% | 0.55% | -7.17% | -30.8% | -26.3% |
| 2019 | 112.76% | -42.68% | -44.08% | -21.86% | -21.19% |
| 2018 | -29.47% | -1.45% | -11.37% | 13.09% | -4.22% |
| 2017 | -50.73% | 16.16% | 28.35% | -18.06% | -8.18% |
| 2016 | 1.8% | 46.89% | 27.84% | 55.21% | 30.5% |
| 2015 | 75.63% | 54.98% | 53.9% | 102.63% | 71.34% |
| 2014 | 60.84% | 100.53% | 106.91% | 110.42% | 89.33% |
| 2013 | 143.7% | 16.96% | -51.67% | -52.48% | 35.03% |
| 2012 | -58.97% | -14.5% | – | – | 36.05% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology